Source link : https://www.newshealth.biz/health-news/hint-of-alzheimers-benefit-seen-with-glp-1-drug/
PHILADELPHIA — A GLP-1 receptor agonist may have the ability to protect cognition in people with mild Alzheimer’s dementia, data from the phase IIb ELAD trial suggested. Liraglutide (Saxenda, Victoza) showed benefit on one of three secondary outcomes that measured cognition, reported Paul Edison, MD, PhD, of Imperial College London, at the Alzheimer’s Association International […]
Author : News Health
Publish date : 2024-07-30 13:21:03
Copyright for syndicated content belongs to the linked Source.
inHealth